Cingulate Inc. ( CING) - Key Metrics
CING Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.45 | -$971.14 | -$980.87 |
| 2026Q1 | $0 | -$1.71 | -$1.27 | -$1.28 |
| 2025Q4 | $0 | -$1.15 | -$0.66 | -$0.69 |
| 2025Q3 | $0 | -$1.35 | -$0.78 | -$0.78 |
| 2025Q2 | $0 | -$1.09 | -$1.09 | -$1.09 |
CING Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -3.04 |
| 2026Q1 | 0% | -0.91 |
| 2025Q4 | 0% | -1.25 |
| 2025Q3 | 0% | -0.73 |
| 2025Q2 | 0% | -0.93 |
CING
Price: $4.72
52 week price:
Earnings Per Share: -3.56 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 16900
Market Capitalization: 65.9 million